CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-28 | BERNS PAUL L See Remarks | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2025-05-28 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −95,586 | 0 | ||
| 2025-05-28 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −27,802 | 0 | ||
| 2025-05-28 | Ho Maykin Director | Returned to the company · Stock Option (Right to Buy) | −28,571 | 0 | ||
| 2025-05-28 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +95,586 | 95,586 | ||
| 2025-05-28 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +27,802 | 27,802 | ||
| 2025-05-28 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2025-05-28 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-05-28 | Halawa Alaa Director | Returned to the company · Stock Option (Right to Buy) | −46,455 | 0 | ||
| 2025-05-28 | Halawa Alaa Director | Returned to the company · Stock Option (Right to Buy) | −28,571 | 0 | ||
| 2025-05-28 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +46,455 | 46,455 | ||
| 2025-05-28 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2025-05-28 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −223,034 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −270,828 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −223,034 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −720,084 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −127,448 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −170,000 | 0 | ||
| 2025-05-28 | Pinto Joshua President | Returned to the company · Stock Option (Right to Buy) | −3,000,000 | 0 |
Page 7 of 20 · 384 trades